Commentary in NEJM Backs Making Hospitals Report Gross Profits from 340B

NEJM
To encourage nonprofit hospitals to do more for their communities, policymakers could examine how hospitals are using their gross profit from the 340B program, an opinion article in The New England Journal of Medicine says.
The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers March to Capitol Hill for Second Straight Year to ‘Defend 340B’

CV340B
Around 50 340B provider advocates marched to the U.S. Capitol yesterday to urge Congress to defend the drug pricing program. Nonprofit group CV340B organized the demonstration.
On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ease 340B Requirements for Generic Drugs to Ease Shortages, Trade Group Tells Congressional Committee Chairs

Pills
Congress should ease 340B requirements for generic drugs to help stem shortages, the trade group for makers of the drugs said in a July 7 white paper.
Low-cost generic drugs should get an exemption from the 340B drug pricing program to help reduce drug shortages, the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Congress Weighs 340B Changes, Leading HIV/AIDS Group Urges it to Support the Program

Washington Examiner
Washington Examiner, a conservative news outlet, published an op-ed by AHF President Michael Weinstein urging Congress to protect 340B from the drug industry.
A leading not-for-profit HIV and AIDS treatment organization amplified its 340B advocacy recently with an op-ed in a Washington, D.C., [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Top Republican on Senate HELP Committee Calls for 340B Transparency and Accountability Action

Bill Cassidy
U.S. Senate HELP Committee ranking Republican Bill Cassidy (La.) said in an op-ed today that Congress should “increase 340B transparency and accountability to preserve the intent of the program.”
U.S. Sen Bill Cassidy (La.), the top Republican on the Senate Health, Education, Labor, and Pensions Committee, said in an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Rep. Matsui Expected to File 340B Contract Pharmacy Bill in Connection with 340B Conference

Doris Matsui
Rep. Doris Matsui (D-Calif.) introduced federal legislation to prohibit drugmaker 340B contract pharmacy restrictions.

A bill amending the 340B statute to explicitly require drug makers to unconditionally sell and deliver 340B drugs dispensed by contract pharmacies is expected to be introduced just before or during the 340B Coalition summer conference July 10-12 near Washington,

Read More »

Maine Enacts Nation’s Second 340B Provider Transparency Law

Maine state capitol
The Maine legislature has passed and Gov. Janet Mills (D) has signed a bill requiring 340B hospitals to report their 340B savings and how they use them.

Maine Gov. Janet Mills (D) signed bipartisan legislation late last week requiring 340B hospitals to submit annual reports consistent with the American Hospital Association’s voluntary 340B good stewardship principles.

The new law made Maine the second state to impose reporting

Read More »

California Senate Passes PBM 340B Nondiscrimination Bill

California state capitol
The California Senate unanimous passed a bill to stop PBMs from discriminating against 340B covered entities and their pharmacies.

The California Senate has unanimously passed a bill to stop pharmacy benefit managers from discriminating against 340B covered entities and their pharmacies.

The Senate voted 35-0 on May 22 to pass SB-786, sponsored by Sen. Anthony Portantino (D). A

Read More »

340B Report Publisher and CEO: What Two State Legislative Sessions Tell Us About the State of 340B Policy

Red state blue state
What do the outcomes of 340B policy debates in a red state and a blue state mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky provides important analysis in his new column for Verity Solutions.

What do the outcomes of 340B policy debates in two state legislatures on opposite ends of the political spectrum mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky gives the most important takeaways in his latest column for

Read More »

Minnesota Imposes Nation’s First 340B Covered Entity Reporting Requirements

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.

Minnesota health care providers were shocked to learn that a bill signed into law in late May made their state the first to require all 340B covered entities to report their total 340B drug acquisition costs and payments.

The first

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live